LEXINGTON, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
report its financial results for the year ended December 31, 2016, on
Monday, March 6, 2017, before the U.S. financial markets open. The
Company will host a conference call and webcast at 8:30 a.m. EST to
discuss 2016 financial results and provide a business update.
Individuals interested in participating in the call should dial (855)
354-1855 (U.S. and Canada) or (484) 365-2865 (International).
In addition, the Company today announced that it will present a
corporate overview at the following upcoming investor conferences:
The 37th Annual Cowen and Company Healthcare Conference on
March 6, 2017 at 2:40 p.m. EST in Boston, MA;
The 29th Annual ROTH Conference on March 14, 2017 at 11:30
a.m. PST in Dana Point, CA; and
The Barclays Global Healthcare Conference on March 16, 2017 at 9:30
a.m. EST in Miami, FL.
A live webcast of these presentations including the fourth quarter
financial results may be accessed in the Investors
section of the Company's website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the fourth quarter financial results
webcast will be available on Concert's website for three months. A
replay of the investor conference webcasts will be available on
Concert's website for two weeks following each presentation.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to address unmet patient needs. The Company's
approach starts with approved drugs in which deuterium substitution has
the potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad
pipeline of innovative medicines targeting pulmonary diseases,
including cystic fibrosis, autoimmune and inflammatory diseases and
central nervous systems (CNS) disorders. For more information please
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170302005160/en/
Concert Pharmaceuticals, Inc.
Justine Koenigsberg, 781-674-5284
Source: Concert Pharmaceuticals, Inc.
News Provided by Acquire Media